MX9800705A - Compuestos heterociclicos, composiciones para tratar isquemia de miocardio que los contiene, y procedimiento para su preparacion. - Google Patents

Compuestos heterociclicos, composiciones para tratar isquemia de miocardio que los contiene, y procedimiento para su preparacion.

Info

Publication number
MX9800705A
MX9800705A MX9800705A MX9800705A MX9800705A MX 9800705 A MX9800705 A MX 9800705A MX 9800705 A MX9800705 A MX 9800705A MX 9800705 A MX9800705 A MX 9800705A MX 9800705 A MX9800705 A MX 9800705A
Authority
MX
Mexico
Prior art keywords
grouping
disclosed
optionally branched
compounds
heterocyclic compounds
Prior art date
Application number
MX9800705A
Other languages
English (en)
Inventor
Jean-Pierre Rieu
Jean-Francois Patoiseau
Gareth W John
Brubo Legrand
Jean-Pierre Valentin
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MX9800705A publication Critical patent/MX9800705A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Se describen N-heterociclil-1-ariloxialquil-4-piperi-dinaminas substituidas novedosas de la formula I, en donde cada uno de R1 a R4 que son los mismos o diferentes, es hidrogeno, opcionalmente alquilo de C1-4 ramificado, opcionalmente, alquiloxi de C1-4 ramificado, un grupo halogeno, un grupo nitro, un grupo trifluorometilo o trifluorometoxi; R5 es hidrogeno, opcionalmente alquilo de C1-6 ramificado, opcionalmente fenilalquilo C7-12 ramificado opcionalmente substituido en el anillo aromático por uno o más radicales que tienen la misma definicion que R1; W y X son oxígeno o azufre, Y es un grupo polimetileno de C2-6 o un radical -Ch2-Ch(OH)-CH2; y n es 0 o 1; también se describen isomeros R o S puros de dichos compuestos, en donde es aplicable, así como mezclas de los mismos; además, se describen sales orgánicos terapéuticamente aceptables de los compuestos de la formula general I, y cualesquiera hidratos de los mismos; finalmente, se describe un método para preparar los compuestos reclamados y su uso como fármacos.
MX9800705A 1995-07-26 1998-01-23 Compuestos heterociclicos, composiciones para tratar isquemia de miocardio que los contiene, y procedimiento para su preparacion. MX9800705A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509079A FR2737207B1 (fr) 1995-07-26 1995-07-26 Nouvelles n-heterocyclyl-1-aryloxyalcoyl-4-piperidinamines substituees, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
MX9800705A true MX9800705A (es) 1998-10-31

Family

ID=9481394

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800705A MX9800705A (es) 1995-07-26 1998-01-23 Compuestos heterociclicos, composiciones para tratar isquemia de miocardio que los contiene, y procedimiento para su preparacion.

Country Status (17)

Country Link
US (1) US6011032A (es)
EP (1) EP0842174B1 (es)
JP (1) JPH11509857A (es)
KR (1) KR19990035986A (es)
CN (1) CN1103338C (es)
AT (1) ATE206423T1 (es)
AU (1) AU707950B2 (es)
BR (1) BR9609911A (es)
CA (1) CA2228691A1 (es)
DE (1) DE69615696T2 (es)
DK (1) DK0842174T3 (es)
ES (1) ES2165514T3 (es)
FR (1) FR2737207B1 (es)
MX (1) MX9800705A (es)
NZ (1) NZ315347A (es)
PT (1) PT842174E (es)
WO (1) WO1997005134A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788771B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
FR2788775B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles n-alcoyl-n-[1-(omega-(arylalcoyloxy)alcoyl] piperidin-4-yl]-4h-3,1-benzo(thia/oxa)zines-2-amines substituees, leur preparation et leur application en therapeutique
AU4314700A (en) * 1999-04-28 2000-11-17 Banyu Pharmaceutical Co., Ltd. Processes for the preparation of piperidylmethylpyridine derivatives
FR3001151B1 (fr) 2013-01-21 2016-04-08 Pf Medicament Association d'un bloqueur de courant sodique lent et d'un inhibiteur du courant if sinusal et les compositions pharmarceutiques la contenant
CN114349745B (zh) * 2022-01-14 2023-12-08 黑龙江中医药大学 一种用于治疗心肌缺血的药物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives

Also Published As

Publication number Publication date
EP0842174A1 (fr) 1998-05-20
EP0842174B1 (fr) 2001-10-04
DK0842174T3 (da) 2002-01-28
CN1193972A (zh) 1998-09-23
AU6703196A (en) 1997-02-26
NZ315347A (en) 2000-01-28
ATE206423T1 (de) 2001-10-15
FR2737207B1 (fr) 1997-10-17
CA2228691A1 (fr) 1997-02-13
JPH11509857A (ja) 1999-08-31
CN1103338C (zh) 2003-03-19
PT842174E (pt) 2002-03-28
DE69615696D1 (de) 2001-11-08
FR2737207A1 (fr) 1997-01-31
WO1997005134A1 (fr) 1997-02-13
ES2165514T3 (es) 2002-03-16
KR19990035986A (ko) 1999-05-25
BR9609911A (pt) 1999-03-02
AU707950B2 (en) 1999-07-22
US6011032A (en) 2000-01-04
DE69615696T2 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
EP1103552A4 (en) BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
NZ336202A (en) Pure enantiomer aryl-cycloalkyl-hydroxycarboxylic acid esters and use in treating smooth muscle spasms and respiritory diseases
ATE215078T1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
AU3461697A (en) Heterocyclic compounds, their production and use
MX9302300A (es) Derivados esteroides para el tratamiento de hipertrofia prostatica, su preparacion y sus usos.
HU9201626D0 (en) Process for the production of 3-amino-piridazines
EP0997462A4 (en) NOVEL NAPHTHYRIDINE DERIVATIVES OR THEIR SALTS
FI101301B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
MX9800705A (es) Compuestos heterociclicos, composiciones para tratar isquemia de miocardio que los contiene, y procedimiento para su preparacion.
NZ503880A (en) Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
HUP0103327A2 (hu) Trombózis-ellenes hatású szubsztituált fenil-amidinek
EP0971899A4 (en) HEXAHYDROINDENOPYRIDINE COMPOUNDS WITH ANTISPERMATOGENIC ACTIVITY
NO952939L (no) Nye substituerte tiosemikarbazontioner
ATE186907T1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
MX9304444A (es) Nuevos derivados de acido piridinecarboxilico, proceso para preparar los mismos.

Legal Events

Date Code Title Description
FG Grant or registration